Intelligence · Clinical Pipeline
S.L Pipeline
All ClinicalTrials.gov programs at S.L — phase, modality, and trial IDs.
- Programs
- 7
Quick answer
S.L has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
CBP-201
S.L
Chronic Rhinosinusitis With Nasal Polyps
1 trial -
CBP-201
S.L
Moderate-to-severe Atopic Dermatitis
2 trials -
CBP-201
S.L
Moderate to Severe Persistent Asthma
1 trial -
Double-Blind 0.2mg CBP-307
S.L
Moderate to Severe Ulcerative Colitis
1 trial -
Rademikibart in prefilled syringe
S.L
Asthma Acute
1 trial -
Rademikibart in prefilled syringe
S.L
COPD Acute Exacerbation
1 trial -
umbilical cord blood (hUCB) cells
S.L
Cerebral Palsy
1 trial
Frequently asked questions
How many pipeline programs does S.L have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs